(Q63394242)

English

Study of hCT-MSC in Newborn Infants With Moderate or Severe HIE

clinical trial

Statements

A Phase I Study of hCT-MSC, an Umbilical Cord-Derived Mesenchymal Stromal Cell Product, in Newborn Infants With Moderate or Severe Hypoxic- Ischemic Neonatal Encephalopathy. (English)
0 references
0 references
0 references
0 references
27 December 2018
0 references
1 November 2020
0 references
6
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit